Cargando…

GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency?

INTRODUCTION: The proportion of patients with low GH response to provocative tests increases with the number of other pituitary hormone deficiencies, reason why in panhypopituitary patients GH stimulation tests may be unnecessary to diagnose GH deficiency (GHD) PURPOSE: To re-evaluate the diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gasco, V., Cuboni, D., Varaldo, E., Bioletto, F., Berton, A. M., Bona, C., Prencipe, N., Ghigo, E., Maccario, M., Grottoli, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514141/ https://www.ncbi.nlm.nih.gov/pubmed/37062055 http://dx.doi.org/10.1007/s40618-023-02081-9

Ejemplares similares

Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone
por: Bioletto, F., et al.
Publicado: (2022)

Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy
por: Bona, C., et al.
Publicado: (2022)

Isolated anterior pituitary dysfunction in adulthood
por: Prencipe, Nunzia, et al.
Publicado: (2023)

Neuroendocrine response to diclofenac in healthy subjects: a pilot study
por: Varaldo, E., et al.
Publicado: (2023)

Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests
por: Bioletto, Fabio, et al.
Publicado: (2021)

Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives
por: Bioletto, Fabio, et al.
Publicado: (2022)

Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment
por: Prencipe, N., et al.
Publicado: (2020)

MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis
por: Bioletto, Fabio, et al.
Publicado: (2022)

Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study
por: Berton, Alessandro Maria, et al.
Publicado: (2023)

Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment
por: Gasco, Valentina, et al.
Publicado: (2021)

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view
por: Berton, A. M., et al.
Publicado: (2020)

Association of Urine Metanephrine Levels with CardiometaBolic Risk: An Observational Retrospective Study
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50–90
por: Carmichael, John D, et al.
Publicado: (2006)

Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
por: Gasco, V., et al.
Publicado: (2022)

Attuali applicazioni della determinazione dei livelli plasmatici di copeptina in contesti non-endocrinologici
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

Mixed gangliocytoma-pituitary adenoma containing GH and GHRH co-secreting adenoma cells
por: Teramoto, Shinichiro, et al.
Publicado: (2019)

AMPK-Dependent Mechanisms but Not Hypothalamic Lipid Signaling Mediates GH-Secretory Responses to GHRH and Ghrelin
por: Vázquez, María J., et al.
Publicado: (2020)

Effects of GHRH Deficiency and GHRH Antagonism on Emotional Disorders in Mice
por: Recinella, Lucia, et al.
Publicado: (2023)

MON-437 Enteroendocrine Connections in Congenital Isolated GH Deficiency Due to GHRH Receptor Gene Mutation
por: Oliveira-Santos, Alecia, et al.
Publicado: (2019)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Crosstalk between Growth and Osmoregulation of GHRH-SST-GH-IGF Axis in Triploid Rainbow Trout (Oncorhynchus mykiss)
por: Xiang, Kaiwen, et al.
Publicado: (2022)

GHRH-GH-IGF1 axis in pediatric Down syndrome: A systematic review and mini meta-analysis
por: Shaki, David, et al.
Publicado: (2023)

First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence
por: Cambria, V., et al.
Publicado: (2021)

Growth Hormone (GH) Deficient Mice With GHRH Gene Ablation Are Severely Deficient in Vaccine and Immune Responses Against Streptococcus pneumoniae
por: Farhat, Khalil, et al.
Publicado: (2018)

P53, GHRH, inflammation and cancer
por: Barabutis, Nektarios, et al.
Publicado: (2018)

Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects
por: Bollati, Martina, et al.
Publicado: (2022)

GH Responsiveness to Combined GH-Releasing Hormone and Arginine Administration in Obese Patients with Fibromyalgia Syndrome
por: Rigamonti, Antonello E., et al.
Publicado: (2017)

Effect of Arginine Infusion on Ghrelin Secretion in Growth Hormone Sufficient and GH Deficient Children
por: Prodam, Flavia, et al.
Publicado: (2012)

A Natural Variant of Obestatin, Q90L, Inhibits Ghrelin's Action on Food Intake and GH Secretion and Targets NPY and GHRH Neurons in Mice
por: Hassouna, Rim, et al.
Publicado: (2012)

Macrophages From Subjects With Isolated GH/IGF-I Deficiency Due to a GHRH Receptor Gene Mutation Are Less Prone to Infection by Leishmania amazonensis
por: Barrios, Mônica R., et al.
Publicado: (2019)

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
por: Villanova, Tania, et al.
Publicado: (2019)

The Application of GHRH Antagonist as a Treatment for Resistant APL
por: Chale, Ravinder S., et al.
Publicado: (2023)

Evaluation of trabeculated mass in patient with non compaction: do we need criteria reappraisal?
por: Frandon, Julien, et al.
Publicado: (2016)

PDK1-FoxO1 pathway in AgRP neurons of arcuate nucleus promotes bone formation via GHRH-GH-IGF1 axis
por: Sasanuma, Hideyuki, et al.
Publicado: (2017)

Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls
por: Melo, Manuela A., et al.
Publicado: (2021)

Is European Medicines Agency (EMA) sepsis criteria accurate for neonatal sepsis diagnosis or do we need new criteria?
por: Tuzun, Funda, et al.
Publicado: (2019)

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
por: Bioletto, Fabio, et al.
Publicado: (2022)

Somatostatin triggers rhythmic electrical firing in hypothalamic GHRH neurons
por: Osterstock, Guillaume, et al.
Publicado: (2016)

Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency
por: Patti, Giuseppa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b7mrv85sar39n78780st04ktdk